Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance
Olabode Oladeinde
摘要： The benefits of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) beyond blood pressure reduction have been proven through many large studies (HOPE, LIFE) in high risk CVD patients;1 post hoc studies have shown reductions in new onset type 2 diabetes mellitus (DM).
机标关键词：
分类号：R5(内科学)
论文发表日期：2007-07-02
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 153-154 )